BioSpace News Archive

XVIVO has decided to close the PrimECC(R) Study for Further Patient Inclusions - Strategic Opportunities will be Evaluated

XVIVO Perfusion AB PrimECC is a solution used to prime the heart-lung machine before heart-surgery.

July 12, 2023
·
3 min read
Business

IGC Reports Financial Results for Fiscal Year Ended March 31, 2023

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced its financial results for the fiscal year ended March 31, 2023 (“Fiscal 2023”).

July 12, 2023
·
10 min read
Controlled Freezing to -196°C: Single Use Support & SCHOTT Pharma Join Forces

Specializing in the growing sector of Advanced Therapy Medicinal Products, the cooperation focuses its efforts on drug delivery solutions and freezing applications for cell and gene therapies.

July 12, 2023
·
2 min read
Biotech Beach

NeuroSigma Establishes Singapore Subsidiary

NeuroSigma, Inc. announced the launch of NeuroSigma Pte, Ltd., a Singapore corporation, representing NeuroSigma’s first foreign subsidiary.

July 12, 2023
·
3 min read
Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients

Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy.

July 12, 2023
·
3 min read
Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan

Regulatory News: Median Technologies reports its business indicators for the first half of 2023 for the iCRO activity and the iBiopsy® activity.

July 12, 2023
·
8 min read
Pharm Country

Kedrion’s global portfolio expands to China to supply human Albumin

Kedrion Biopharma has announced that China’s National Institutes for Food and Drug Control has approved BPL’s human Albumin product for release to the Chinese market.

July 12, 2023
·
3 min read
Business

BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer

BrainStorm Cell Therapeutics Inc. today announced the appointment of Bob Dagher , MD, as Executive Vice President and Chief Development Officer effective July 17, 2023.

July 12, 2023
·
5 min read
Biotech Bay

Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference

Nevro Corp. today announced that Kevin Thornal , Nevro’s CEO and President, and Rod MacLeod , Nevro’s CFO, will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023 at 8:30 am Eastern Time at the InterContinental Boston Hotel in Boston, MA.

July 12, 2023
·
2 min read
Business

IDEXX Laboratories Elects Irene Chang Britt to Board of Directors

IDEXX Laboratories, Inc. today announced the election of Irene Chang Britt, a former executive at Campbell Soup Company, to the Company’s Board of Directors, effective July 11, 2023.

July 12, 2023
·
3 min read